These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 15687223)
1. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223 [TBL] [Abstract][Full Text] [Related]
2. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior. Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030 [TBL] [Abstract][Full Text] [Related]
3. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876 [TBL] [Abstract][Full Text] [Related]
4. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Chen G; Huang LD; Jiang YM; Manji HK J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507 [TBL] [Abstract][Full Text] [Related]
5. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101 [TBL] [Abstract][Full Text] [Related]
6. The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities. Gotfryd K; Hansen M; Kawa A; Ellerbeck U; Nau H; Berezin V; Bock E; Walmod PS Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):164-74. PubMed ID: 21439023 [TBL] [Abstract][Full Text] [Related]
7. A common mechanism of action for three mood-stabilizing drugs. Williams RS; Cheng L; Mudge AW; Harwood AJ Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604 [TBL] [Abstract][Full Text] [Related]
8. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158 [TBL] [Abstract][Full Text] [Related]
9. Structure-function studies for the panacea, valproic acid. Terbach N; Williams RS Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465 [TBL] [Abstract][Full Text] [Related]
10. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death. Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder. Azab AN; Vainer E; Agam G; Bersudsky Y J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616 [TBL] [Abstract][Full Text] [Related]
12. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods. Lampen A; Göttlicher M; Nau H ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687 [TBL] [Abstract][Full Text] [Related]
13. Valproate recovers the inhibitory effect of dexamethasone on the proliferation of the adult dentate gyrus-derived neural precursor cells via GSK-3β and β-catenin pathway. Boku S; Nakagawa S; Masuda T; Nishikawa H; Kato A; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Kusumi I Eur J Pharmacol; 2014 Jan; 723():425-30. PubMed ID: 24211784 [TBL] [Abstract][Full Text] [Related]
14. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain. Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders. Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518 [TBL] [Abstract][Full Text] [Related]
16. GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Jonathan Ryves W; Dalton EC; Harwood AJ; Williams RS Bipolar Disord; 2005 Jun; 7(3):260-5. PubMed ID: 15898963 [TBL] [Abstract][Full Text] [Related]
17. Regulation of Glycogen Content in Astrocytes via Cav-1/PTEN/AKT/GSK-3β Pathway by Three Anti-bipolar Drugs. Jia S; Li B; Huang J; Verkhratsky A; Peng L Neurochem Res; 2018 Aug; 43(8):1692-1701. PubMed ID: 29968232 [TBL] [Abstract][Full Text] [Related]
18. Inositol synthesis regulates the activation of GSK-3α in neuronal cells. Ye C; Greenberg ML J Neurochem; 2015 Apr; 133(2):273-83. PubMed ID: 25345501 [TBL] [Abstract][Full Text] [Related]
19. Search for a common mechanism of mood stabilizers. Harwood AJ; Agam G Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261 [TBL] [Abstract][Full Text] [Related]